B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
about
Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolutionNodal and leukemic small B-cell neoplasmsMonoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratificationExhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patientsA case of CLL that was successfully treated resulted in the immediate development of AML from a coexistent myeloid line that had been suppressed.Immunologic aspects of monoclonal B-cell lymphocytosisIncidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelinesCommon occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.New insights into monoclonal B-cell lymphocytosis.Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working groupThe 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsReassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis.Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.Prevalence of monoclonal B lymphocytosis in first-degree relatives of chronic lymphocytic leukemia patients in Turkey.Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemiaHLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.Precursors to lymphoproliferative malignancies.Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical managementOccult B-cell lymphoproliferative disorders.Monoclonal B-cell lymphocytosis: a brief review for general clinicians.Clinical aspects of monoclonal B-cell lymphocytosis.Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.The current lymphoma classification: new concepts and practical applications triumphs and woes.Monoclonal B cell lymphocytosis--what does it really mean?A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.Lymphoma classification update: B-cell non-Hodgkin lymphomas.A classification tree approach for improving the utilization of flow cytometry testing of blood specimens for B-cell non-Hodgkin lymphoproliferative disorders.Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia.Another piece of the puzzle: is there a "nodal" monoclonal B-cell lymphocytosis?Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis.A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
P2860
Q26823586-FDA4A85F-AE78-4A1E-9B19-89ED7FEF9A3DQ26829315-44289AB9-166C-4AB9-BBFA-EBFCD0A791BAQ28082120-F8BB3634-B08C-47BA-8A30-5E51BD402358Q30421637-9ADCA400-BF06-45BD-BADA-1823BA6A9ECBQ33421691-46C0787C-5BC8-4002-B216-D30B89DA01C8Q33915138-1D7D484D-9382-48BC-80BC-82F69BDDF985Q34014125-D168F786-D548-455B-AB63-0D0743F00A65Q34253252-97B45AFE-7DA4-4208-8ABC-3DBDBA621E6CQ34256898-BAD7AFC4-E355-4193-9938-DBE62F300268Q34441264-A622EFCD-7A9A-4CEE-B5F4-FC8D10809FF2Q34543041-233E3CD1-E496-4C6A-85BD-8FDF3906E35CQ35029409-9327A17E-FE90-458E-AEBC-8B9AE9072804Q35143475-914CCF81-2EA8-4D43-AED4-60F26BC4F804Q35188629-518BAFC0-35C6-4EBD-BD4B-F56AE089A90BQ35569491-4FA83F93-8E4B-4CD6-B442-99B6E4E87729Q35631546-3A4E09F0-3F30-4172-9164-5D7DFB83944EQ36022532-03F6FBA2-F257-481A-9C70-3017DAAB530EQ36294042-D75F355D-DDD4-4361-9E62-00FC98B47634Q36739877-5A943AB5-41E7-44DB-879C-038FD1CCE835Q36822986-9C0F667D-0D39-423A-9033-AC295A4DE6BAQ37175576-423F908E-A852-42BF-81F3-2E7DB239FE73Q37188389-FAF79680-D6F0-4E87-9004-0D03E7909016Q37324992-20E6B506-87EF-400D-99CC-C66E1E7A4E05Q37483454-8F71DE81-A082-4101-AF28-D8897246BC6AQ37517160-9CDB23FD-BCA1-4B31-A384-A00D81C4B070Q37552813-802F13C6-E60E-4F2A-827D-2AA149C948D5Q37831957-F375038B-96BD-434E-9A82-04D1CBDB066DQ37900875-81B47943-D7A9-441F-ADE1-E0FCB24045CAQ37964913-5945D78E-1248-4B3E-8C1C-58A6CD0F8C2EQ37984121-71E2BDB9-7243-4981-9A2A-5BF34D83A04CQ38010331-38CC38CA-C926-4F4B-B39A-04E57ECB99C9Q38073187-EBF0D95E-0146-4477-A53B-CA09BDB8214DQ38839768-1EC60FC2-3379-47D1-B21C-0B03DFC34887Q38843988-A218149C-0424-4A45-8ECD-691678F2B974Q41479781-F629E4B8-3A5E-4558-BF44-5B54B45C74F6Q41500318-BF22F6B3-2B75-4B9D-8492-33098B8915C5Q42852358-1B712297-EA72-40DA-BBDD-3EDD51A7D0FAQ44121849-4BE0727A-B1C7-4F7D-9567-B8598E7DDBE6Q44173014-F763A3DD-2FF2-4742-86A7-99A743720449Q44736805-57E8C1D7-9825-496E-876F-65FC46A6C025
P2860
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
B-cell count and survival: dif ...... sis based on clinical outcome.
@en
B-cell count and survival: dif ...... sis based on clinical outcome.
@nl
type
label
B-cell count and survival: dif ...... sis based on clinical outcome.
@en
B-cell count and survival: dif ...... sis based on clinical outcome.
@nl
prefLabel
B-cell count and survival: dif ...... sis based on clinical outcome.
@en
B-cell count and survival: dif ...... sis based on clinical outcome.
@nl
P2093
P2860
P1433
P1476
B-cell count and survival: dif ...... sis based on clinical outcome.
@en
P2093
Clive S Zent
Curtis A Hanson
Diane F Jelinek
Greg Jenkins
Justin Boysen
Liam Zakko
Neil E Kay
Susan L Slager
Susan Schwager
Tait D Shanafelt
P2860
P304
P356
10.1182/BLOOD-2008-09-176149
P407
P577
2008-11-17T00:00:00Z